company background image
COLO B logo

Coloplast CPSE:COLO B Stock Report

Last Price

DKK 874.80

Market Cap

DKK 198.3b

7D

-4.3%

1Y

13.4%

Updated

21 Nov, 2024

Data

Company Financials +

Coloplast A/S

CPSE:COLO B Stock Report

Market Cap: DKK 198.3b

COLO B Stock Overview

Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. More details

COLO B fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance3/6
Financial Health2/6
Dividends3/6

Rewards

Trading at 41.9% below our estimate of its fair value

Earnings are forecast to grow 12.85% per year

Earnings have grown 4.9% per year over the past 5 years

Risk Analysis

Debt is not well covered by operating cash flow

Dividend of 2.51% is not well covered by earnings or free cash flows


Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Operational Efficiencies And Innovations In Urology And Wound Care Propel Future Growth

Key Takeaways Improved operational efficiency and strategic expansions are expected to enhance net margins and earnings over the long term. Strategic acquisitions and growth in niche markets are projected to boost revenue and transform key business segments.
View narrative
DKK 923.24
FV
5.2% undervalued intrinsic discount
8.50%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Updated narrative

Coloplast A/S Competitors

Demant

CPSE:DEMANT

DKK 56.5b

Ambu

CPSE:AMBU B

DKK 30.0b

Embla Medical hf

CPSE:EMBLA

DKK 15.3b

Cooper Companies

NasdaqGS:COO

US$19.7b

Price History & Performance

Summary of all time highs, changes and price drops for Coloplast
Historical stock prices
Current Share PriceDKK 874.80
52 Week HighDKK 977.60
52 Week LowDKK 744.00
Beta0.34
11 Month Change-2.63%
3 Month Change-5.30%
1 Year Change13.40%
33 Year Change-20.26%
5 Year Change8.11%
Change since IPO6,746.26%

Recent News & Updates

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 13
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Nov 08
Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Recent updates

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 13
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Nov 08
Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Oct 18
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 23
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Aug 22
Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

Jul 17
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jun 29
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Shareholder Returns

COLO BDK Medical EquipmentDK Market
7D-4.3%-0.3%-1.0%
1Y13.4%10.9%7.5%

Return vs Industry: COLO B exceeded the Danish Medical Equipment industry which returned 10.9% over the past year.

Return vs Market: COLO B exceeded the Danish Market which returned 7.5% over the past year.

Price Volatility

Is COLO B's price volatile compared to industry and market?
COLO B volatility
COLO B Average Weekly Movement3.4%
Medical Equipment Industry Average Movement3.6%
Market Average Movement4.2%
10% most volatile stocks in DK Market10.5%
10% least volatile stocks in DK Market2.5%

Stable Share Price: COLO B has not had significant price volatility in the past 3 months compared to the Danish market.

Volatility Over Time: COLO B's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195416,639Kristian Villumsenwww.coloplast.com

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Coloplast A/S Fundamentals Summary

How do Coloplast's earnings and revenue compare to its market cap?
COLO B fundamental statistics
Market capDKK 198.34b
Earnings (TTM)DKK 5.05b
Revenue (TTM)DKK 27.03b

39.0x

P/E Ratio

7.3x

P/S Ratio

Is COLO B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
COLO B income statement (TTM)
RevenueDKK 27.03b
Cost of RevenueDKK 8.76b
Gross ProfitDKK 18.27b
Other ExpensesDKK 13.22b
EarningsDKK 5.05b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 04, 2025

Earnings per share (EPS)22.44
Gross Margin67.59%
Net Profit Margin18.69%
Debt/Equity Ratio120.6%

How did COLO B perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

98%

Payout Ratio

Does COLO B pay a reliable dividends?

See COLO B dividend history and benchmarks
When do you need to buy COLO B by to receive an upcoming dividend?
Coloplast dividend dates
Ex Dividend DateDec 06 2024
Dividend Pay DateDec 10 2024
Days until Ex dividend14 days
Days until Dividend pay date18 days

Does COLO B pay a reliable dividends?

See COLO B dividend history and benchmarks